Not recruitingISRCTN20328848
Primary prevention of psychosis through interventions in the prodromal phase
Research studyNorwaySchizophrenia
Understand this study
- Listed locations
- Norway
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Stavanger University Hospital (Norway)
- Sponsor type
- Hospital / academic medical center
- Study type
- Other
- Intervention type
- Other / unclear
- Locations
- Norway
- Age range
- Not clearly listed
- Official registry ID
- ISRCTN20328848
- Official title
Show the full official title
Primary prevention of psychosis through interventions in the prodromal phase
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Norway
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Stavanger University Hospital (Norway), a hospital or academic medical center.
Is this study still recruiting?
The registry lists this study as not recruiting.
Want to explore more studies?
Explore studiesRelated studies
An open label, single arm, extension trial to examine long-term safety of BI 425809 once daily in patients with schizophrenia who have completed previous BI 425809 Phase III trials.(CONNEX-X)
Standard or shorter high-intensity exercise for schizophrenia-spectrum conditions or bipolarity
